APA (7th ed.) Citation

Wu, Y., Kong, J., Chen, J., Gu, Y., Wang, H., Jin, X., . . . Xie, F. (2026). Anti-HER2 nanobody 5F7-based theranostics using [68Ga]Ga-NOTA-5F7 PET/CT and [131I]SGMIB-5F7 SPECT/CT in HER2-positive breast cancer. European Journal of Nuclear Medicine & Molecular Imaging, 53(9), 5277. https://doi.org/10.1007/s00259-026-07870-x

Chicago Style (17th ed.) Citation

Wu, Yanfei, et al. "Anti-HER2 Nanobody 5F7-based Theranostics Using [68Ga]Ga-NOTA-5F7 PET/CT and [131I]SGMIB-5F7 SPECT/CT in HER2-positive Breast Cancer." European Journal of Nuclear Medicine & Molecular Imaging 53, no. 9 (2026): 5277. https://doi.org/10.1007/s00259-026-07870-x.

MLA (9th ed.) Citation

Wu, Yanfei, et al. "Anti-HER2 Nanobody 5F7-based Theranostics Using [68Ga]Ga-NOTA-5F7 PET/CT and [131I]SGMIB-5F7 SPECT/CT in HER2-positive Breast Cancer." European Journal of Nuclear Medicine & Molecular Imaging, vol. 53, no. 9, 2026, p. 5277, https://doi.org/10.1007/s00259-026-07870-x.